U2AF1 mutation types in primary myelofibrosis: phenotypic and prognostic distinctions

Insights from structures of cancer-relevant pre-mRNA splicing factors

(2018) Clara L Kielkopf   CURRENT OPINION IN GENETICS & DEVELOPMENT

Revised cytogenetic risk stratification in primary myelofibrosis: analysis based on 1002 informative patients

(2018) Ayalew Tefferi et al.   LEUKEMIA

Clinical features and biological implications of different U2AF1 mutation types in myelodysplastic syndromes

(2017) Bing Li et al.   GENES CHROMOSOMES & CANCER

The U2AF1S34F mutation induces lineage-specific splicing alterations in myelodysplastic syndromes

(2017) Bon Ham Yip et al.   JOURNAL OF CLINICAL INVESTIGATION

Prognostic significance of ASXL1 mutation types and allele burden in myelofibrosis

(2017) A Tefferi et al.   LEUKEMIA

Spliceosomal gene mutations in myelodysplasia: molecular links to clonal abnormalities of hematopoiesis

(2016) Daichi Inoue et al.   GENES & DEVELOPMENT

Therapeutic targeting of splicing in cancer

(2016) Stanley Chun-Wei Lee et al.   NATURE MEDICINE

U2AF1mutations alter splice site recognition in hematological malignancies

(2014) Janine O. Ilagan et al.   GENOME RESEARCH

Clinical implications of U2AF1 mutation in patients with myelodysplastic syndrome and its stability during disease progression

(2013) Shang-Ju Wu et al.   AMERICAN JOURNAL OF HEMATOLOGY

U2AF1 mutations in primary myelofibrosis are strongly associated with anemia and thrombocytopenia despite clustering with JAK2V617F and normal karyotype

(2013) A Tefferi et al.   LEUKEMIA

Mutations and prognosis in primary myelofibrosis

(2013) A M Vannucchi et al.   LEUKEMIA

Spliceosome mutations involvingSRSF2,SF3B1, andU2AF35in chronic myelomonocytic leukemia: Prevalence, clinical correlates, and prognostic relevance

(2012) Mrinal M. Patnaik et al.   AMERICAN JOURNAL OF HEMATOLOGY

SF3B1 mutations in primary myelofibrosis: clinical, histopathology and genetic correlates among 155 patients

(2011) T L Lasho et al.   LEUKEMIA

The 2008 revision of the World Health Organization (WHO) classification of myeloid neoplasms and acute leukemia: rationale and important changes

(2009) J. W. Vardiman et al.   BLOOD

A dynamic prognostic model to predict survival in primary myelofibrosis: a study by the IWG-MRT (International Working Group for Myeloproliferative Neoplasms Research and Treatment)

(2009) F. Passamonti et al.   BLOOD